the report is here: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM199561.pdf
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint